- 米国企業
- BIOGEN INC.
BIOGEN INC.BIIB
時価総額
$335.2億
PER
27.5倍
2010年 12月31日 | 2011年 12月31日 | 2012年 12月31日 | 2013年 12月31日 | 2014年 12月31日 | 2015年 12月31日 | 2016年 12月31日 | 2017年 12月31日 | 2018年 12月31日 | 2019年 12月31日 | 2020年 12月31日 | 2021年 12月31日 | 2022年 12月31日 | 2023年 12月31日 | |
Cash and cash equivalents | - | - | - | - | - | - | - | - | - | - | 1,331 | 2,261 | 3,419 | 1,050 |
Marketable securities | - | - | - | - | - | - | - | - | - | - | 1,279 | 1,541 | 1,474 | - |
Accounts Receivable, after Allowance for Credit Loss, Current | 605 | 585 | 687 | 824 | 1,292 | 1,227 | 1,442 | 1,787 | 1,959 | 1,881 | 1,914 | 1,549 | 1,705 | 1,664 |
Due from unconsolidated joint business | 222 | 229 | 268 | 253 | 283 | 315 | 301 | 533 | 527 | 590 | 414 | 412 | 431 | 436 |
Inventory | - | 327 | 447 | 659 | 804 | 893 | 1,002 | 903 | 930 | 804 | 1,069 | 1,352 | 1,344 | 2,527 |
Other current assets | 216 | 145 | 136 | 226 | 447 | 837 | 1,093 | 962 | 688 | 631 | 881 | 741 | 1,418 | 1,182 |
Total current assets | 2,540 | 2,975 | 3,244 | 3,185 | 4,673 | 6,700 | 8,732 | 7,873 | 7,641 | 8,382 | 6,887 | 7,857 | 9,791 | 6,859 |
Marketable securities | - | - | - | - | - | - | - | - | - | - | 772 | 892 | 706 | - |
Property, plant and equipment, net | 1,642 | 1,571 | 1,742 | 1,751 | 1,766 | 2,188 | 2,502 | 3,182 | 3,601 | 3,247 | 3,412 | 3,416 | 3,299 | 3,310 |
Operating lease assets | - | - | - | - | - | - | - | - | - | 427 | 433 | 375 | 404 | 420 |
Intangible assets, net | 1,773 | 1,608 | 1,632 | 4,475 | 4,029 | 4,085 | 3,808 | 3,880 | 3,120 | 3,527 | 3,084 | 2,221 | 1,850 | 8,363 |
Goodwill | 1,146 | 1,146 | 1,201 | 1,233 | 1,760 | 2,664 | 3,669 | 4,633 | 5,706 | 5,758 | 5,762 | 5,761 | 5,749 | 6,219 |
Deferred tax asset | - | - | - | - | - | - | - | - | - | - | 1,370 | 1,415 | 1,226 | 929 |
Other Assets, Noncurrent | 248 | 332 | 274 | 594 | 619 | 1,108 | 1,336 | 1,028 | 1,691 | 1,253 | 2,899 | 1,940 | 1,529 | 745 |
Total assets | 8,092 | 9,050 | 10,130 | 11,863 | 14,317 | 19,505 | 22,877 | 23,653 | 25,289 | 27,234 | 24,619 | 23,877 | 24,554 | 26,845 |
Debt, Current | - | - | - | 3 | 3 | 5 | 5 | 3 | - | 1,496 | - | 999 | - | 150 |
Taxes payable | 85 | 46 | 20 | 180 | 168 | 209 | 232 | 68 | 64 | 71 | 142 | 175 | 260 | 257 |
Accounts payable | 163 | 186 | 204 | 220 | 229 | 267 | 280 | 396 | 371 | 531 | 455 | 589 | 492 | 403 |
Accrued expense and other | 666 | 677 | 980 | 1,355 | 1,819 | 2,097 | 2,904 | 2,901 | 2,861 | 2,766 | 3,145 | 2,535 | 2,521 | 2,624 |
Total current liabilities | 1,050 | 913 | 1,657 | 1,758 | 2,220 | 2,578 | 3,420 | 3,368 | 3,295 | 4,864 | 3,742 | 4,298 | 3,273 | 3,434 |
Notes payable | - | - | - | 592 | 582 | 6,522 | 6,513 | 5,935 | 5,937 | 4,459 | 7,426 | 6,274 | 6,281 | - |
Notes Payable, Noncurrent | 1,066 | 1,061 | 687 | - | - | - | - | - | - | - | - | - | - | 6,788 |
Deferred tax liability | - | - | - | - | - | - | - | - | - | - | 1,033 | 695 | 335 | 642 |
Long-term operating lease liabilities | - | - | - | - | - | - | - | - | - | 413 | 402 | 330 | 333 | 400 |
Other long-term liabilities | 326 | 400 | 604 | 659 | 650 | 906 | 723 | 1,629 | 1,389 | 1,349 | 1,330 | 1,321 | 944 | 781 |
Total liabilities | 2,643 | 2,623 | 3,166 | 3,242 | 3,503 | 10,130 | 10,748 | 11,055 | 12,257 | 13,895 | 13,933 | 12,918 | 11,166 | 12,045 |
Preferred Stock, Value, Issued | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Common Stock, Value, Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
Common Stock, Value, Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | 0 |
Additional paid-in capital | 3,895 | 4,185 | 3,855 | 4,024 | 4,196 | - | - | 98 | - | - | - | 68 | 73 | 303 |
Accumulated other comprehensive income (loss) | -22 | -27 | -55 | -28 | -59 | -224 | -320 | -318 | -240 | -135 | -299 | -107 | -165 | -154 |
Retained earnings | 1,872 | 3,107 | 4,487 | 6,349 | 9,284 | 12,208 | 15,072 | 15,810 | 16,257 | 16,455 | 13,976 | 13,912 | 16,467 | 17,628 |
Treasury stock, at cost; 23.8 million and 23.8 million shares, respectively | 350 | 840 | 1,325 | 1,725 | 2,612 | 2,612 | 2,612 | 2,977 | 2,977 | 2,977 | 2,977 | 2,977 | 2,977 | 2,977 |
Total Biogen Inc. shareholders’ equity | 5,449 | 6,427 | 6,964 | 8,621 | 10,814 | 9,375 | 12,140 | 12,613 | 13,040 | 13,343 | 10,700 | 10,960 | 13,398 | 14,799 |
Noncontrolling interests | 53 | 1 | 2 | 1 | 5 | 2 | -11 | -15 | -8 | -4 | -14 | 64 | -9 | - |
Total equity | 5,449 | 6,427 | 6,964 | 8,621 | 10,814 | 9,375 | 12,129 | 12,598 | 13,032 | 13,339 | 10,686 | 10,960 | 13,388 | 14,799 |
Total liabilities and equity | 8,092 | 9,050 | 10,130 | 11,863 | 14,317 | 19,505 | 22,877 | 23,653 | 25,289 | 27,234 | 24,619 | 23,877 | 24,554 | 26,845 |